Johnson & Johnson Vision, Care Inc. today announced the U.S. launch of ACUVUE® VITA™ Brand, a 30-day daily wear contact lens with new HydraMax™ Technology that provides superior comfort all month long over other leading monthly brands.

In recent surveys of monthly contact lens wearers, more than two-thirds of respondents said they experience comfort related issues with their lenses at some time during the month, and 84% of these patients use compensating behaviors such as re-wetting drops or taking breaks from wearing their contact lenses. In addition, of those patients experiencing comfort related issues, 73% reported that they did not plan to tell their doctor about their lens wearing experience because most considered their comfort issues “normal.Some raised concerns that if they did so, this would lead to their doctors taking them out of contact lenses.

“While we continue to believe that a shorter wearing cycle is better in contact lenses, these survey results shine a light on the critical unmet need in the monthly category” said Zohra Fadli, Ph.D., Global Platform Lead Reusable Sphere, Johnson & Johnson Vision Care, Inc. “These patient insights helped us recognize the challenges that monthly wearers face and drove our commitment to provide them with a meaningful solution. We know that a change in lens hydration may contribute to a decline in monthly lens comfort, so we focused our efforts on designing a lens that helps maximize and maintain lens hydration, providing reliable, superior comfort all month long.

When compared to other leading monthly brands (Air Optix® Aqua, Biofinity® and Ultra™), patient ratings for ACUVUE® VITA™ were superior for ‘Overall Comfort’ at Weeks 1, 2, 3 & 4. Even competitors’ ‘Overall Comfort’ at Week 1 could not beat ACUVUE® VITA™ comfort at Week 4.

ACUVUE® VITA™ with HydraMax™ Technology is a new non-coated silicone hydrogel formulation. This Eye-Inspired™ Design helps:

Maximize and maintain lens hydration all month long

Enhance comfort through a unique Infinity Edge™

Provide UV protection by blocking approximately 93.4% of UVA rays and 99.8% of UVB rays

“Optimal hydration was our goal for this new innovation,” said Peter Shen, Ph.D., Vice President, Worldwide Research & Development, Johnson & Johnson Vision Care, Inc. “The HydraMax™ Technology in ACUVUE® VITA™ helps maximize lens hydration by integrating the maximum amount of hydrating agent in this lens and then, maintains hydration through optimal density and distribution of beneficial lipids throughout this lens.

Some lens materials are not able to optimally integrate and distribute lipids; this can lead to lipids aggregating on the lens surface and ultimately to deposit formation. The material in ACUVUE® VITA™, senofilcon C, is designed to integrate the optimal density and distribution of beneficial lipids throughout this lens, while maintaining a low deposition profile. A natural function of lipids in the tears is to help protect against tear film evaporation. ACUVUE® VITA™ leverages the function of these beneficial lipids to help maintain lens hydration with a reduced evaporation rate through this lens. In fact, the evaporation rate of ACUVUE® VITA™ is 33% lower than other leading monthly brands.

For more information, visit